Thank report you, Caroline. [indiscernible] encouraged joining the thank first to sequential Good growth another We're positive XXXX. and everyone us. revenue from for you quarter of quarter with afternoon
our the as of technology-enabled Services and As business own a retail model and Technology proprietary two as customers using the has reminder, segments: provision operation pharmacy our our or business high-touch support their large these Retail to technologies technology Pharmacy segment; of Pharmacy to sale known operations, pharmacy known segment. processes our our
revenue in for second and representing increase XXX% quarter increase Pharmacy a the year-over-year first segment million XX% XXXX. Services of Retail from $X.X of quarter Our generated XXXX, a
quarter XX% Technology to second decreased Our in of the XXXX revenues $XXX,XXX. Pharmacy year-over-year
more call, we our all vaccinations COVID many due clients in attempting resulted of on operations, mentioned our deployments quarter and half June. in occurring first during earnings normal to deployments focus first As resume their of delayed which our to
the organic revenue growth had for of As second clinics achieved year-end such, the was our through double-digit sequential XXXX. installed continued by growth we quarter
the will XX as of return that cautiously expansions We the visit in Health, are clinics of clinic remain with back install We XXXX. optimistic to new did such were clients CareMore. levels OptumCare pleased half report XX that Street volumes June. Oak we and to XX pre-COVID in
As new most our there with installations, steps. client two are of
dispense which the approximately XXXX us from at to on-site which state, window, new of the the our and for Pharmacy, we discussions now into Pharmacy, Pharmacy the deploy physical In time the twelve a we four-week outlook. our based clinics to in balance These other we of future. of Board an on to inspection likely these begin Our been experience expectation and Boards calendar installation generate and pressures Due the full this between plans. [indiscernible] Therefore, year, they dispense the foreseeable the built to the by physical which for pushed weeks to XXXX, and was appreciable that first impact our revenue expect time our revenue quarter to with on continue the Boards of not allows clinics. to have in for had fourth external ability XXXX. are to installation eight of year least generate new changes impacts And any revenue. generate revenue lines
to previous calls, value is and by which our focused model adherence clinics care on-site as partner on and viewed discussed have our and clinics a care providers is The we satisfaction. providers. As medication the proposition the with are true embedded in pharmacy fueled customer on we improving partnership
payers customer percentage outcomes with target high at-risk fully and are an business patients, that Medicare fee-for-service Our model care management quality built quality model clinics service. have advantage old of all high the clients so of around common high and for the systems versus incentivized models, run
is evaluated base, are growth with who is As it we our current installed our that these attributes. have encouraging aligned with clients total
our do identified several As we that enhanced not target our have we clinic forward. capabilities, analytical meet expectations going have clinics
transition begun of COVID-XX the height As they to period. from have
anomaly a redeployed our of XXXX, to our sites that with our exit be does approximately now our small in in a we into deployment fit year-end removal effect now The we valuable resources this of more not not decision prior a that feel Medicare in resources, clinics these SpotRx and XX clinics in fit sites. We minimum from these closely deploying We to view advantage albeit clinics approximately long-term greater clinics XXXX, model. ramp, XX withdraw have disproportionate the between up we XX and to exit Therefore, to decided target expect expectation redeploy which of do model. that as clinic of core our new can was XXXX. to our taking one amount year-end
solution With key these and our we operating, base we currently our of Demand clinics that in remains we California, the including reset and of aligned for are clinics strong withdrawals, are have Michigan, in Arizona, the pipeline all states Florida. with our where criteria. our feel
back normal operations. are most more see we outlook, to partners of XXXX our Regarding encouraged moving our clinic to
monthly result, saw services net July, revenue in sequential to retail we compared pharmacy of growth a X% As June.
volume the are robustly, of levels However, to business return continues in we will the XXXX. that clinics half second while to grow pre-COVID cautious
between We from headwinds decision unanticipated clinics approximately our XX timing XXXX. to in and have with of the Boards encountered described withdraw Pharmacy year-end I of approvals now regulatory
result, net full least guidance compared As $XX $XX are at full revenue year to $XX million. to in our to our a we guidance previous year adjusting million net revenue be of million
in its over expect returns customer revenue expect an in maintain we and recognition due old adjustment levels pre-COVID large agreement, the Excluding world XXXX growth associated to this to XXXX, XXX% year, course. rate grow that in to with the assuming one-time
a from year-over-year same Turning of period Pharmacy year-over-year from contribution margins The margin to a reduction relatively was due The in Technology to primarily Services experienced the flat. gross Retail in decrease prior is lower segment. margins. in We Pharmacy gross the our our year. margins segment
delivery initiatives by our the the reduction continue balance We we have improved and XXXX, of margins to gross cost driven terms. focus of as continued the such procurement on through previously discussed, improving in
the markets our new and regions. repeatable, Over highly to regions expand model in within we and long-term, existing scalable is as additional
as the of potential the markets of do XXXX, and U.S. region future to and overhead works in the costs highly traditional growth have. not remain for the the have our to the our second important be entering operations believe You'll cost half to retail of the we store We further demonstrate repeatable recall pharmacy nature scalable this excited footprint advantage, across business that model in structure and target large that carry our Florida
clients addition, as Texas discussed we our key remains have MedAvail. market strategic in for In previously, a
August We our passed MedCenter Board state. at to deploy proprietary that Texas MedAvail allowed are widely the rules permanent Pharmacy the meeting, throughout pleased to were technology announce X, of that
have clinic a IngenioRx, SpotRx will low care be Southern business addition meaningful should have progress, several Tucson the transfer higher subsidiary wish connects California rates. the efforts, partnership Advantage covered out Zipdrug the Zipdrug their new chronic of to we with recent members as patients patient by with working have announce also were is who utilizing Pharmacy pharmacies of proven the adherence by been many to connects be the pharmacies. honored these to or In which In of services PBM, to retail thousands to medications SpotRx of drive will to. best able are possible conditions Zipdrug track development Tucson to Solutions as pharmacy. are in recently area IngenioRx with serving lives a impactful with only we SpotRx in Medicare where lowest record wholly-owned to of Zipdrug, preferred pleased Anthem, both high-performing our independent pharmacy program, Technology Zipdrug’s area made providing retail our be performing that considered pharmacies they geographic cost. be their segments. participate preferred in by We expansion network and the selected pharmacies in solutions through connected on also one adherence with consumers for to opportunities
our thresholds pharmacy Florida. as in selected states, currently significant be ability performance Our partnership quality available a to a meet pharmacy. California, underscoring with and Zipdrug of including Arizona a important milestone, network and is partner represents to number Zipdrug’s
Zipdrug to in partnership coming We expanding our are looking with months. forward the
to segment. Turning Technology our Pharmacy Solutions
value review initial Epic’s integration of nation, targeted that deployed in delighted of with In software enhances to XXXX and will large delivered further The systems pharmacy software. growth, the would of in of integration Epic in reiterate with XXXX, another a upon the integration to services excluding excess XXX% the a health the MedCenters see announce proposition. technology expedited like closing, MedCenter our on EHR the new ahead. proprietary into call geographies. of to and expansions be deliver Epic agreement an in our opportunities XXXX, growth five quarter against for its based With EHR quarter strong executing integration expect demand this our growth and associated to to revenue the we technology XXXX, advantage of we remain I’ll MedAvail. Brian to an rate over with the for one our focused to onetime integration provide turn the largest allow our agreement the maintain manner. given in ongoing Providence, that, with late and recognition agreement MedAvail are care completion of revenue the new that line our we technology in customer through top pharmacy has in I Epic take expect now system pharmacy deploy begun to The we technology second result. retail financial seamless we have MedAvail We customers offerings